Company ESG Risk Ratings

Grünenthal Pharma GmbH & Co. KG

Industry Group: Pharmaceuticals

Country/Region: Germany

Identifier: -

ESG Risk Rating

Medium Risk


Industry Group (1st = lowest risk)

Pharmaceuticals 91 out of 887


Global Universe 4920 out of 15518

Last Update: May 13, 2023

What are the ESG Risk Ratings?

Compare Grünenthal Pharma GmbH & Co. KG with other industry peers.

Industry Comparison

Company ESG Risk Rating Industry Rank
Grünenthal Pharma GmbH & Co. KG
91 out of 887
STADA Arzneimittel AG
99 out of 887

For corporate professionals interested in direct competitor insights

Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.

Our Approach to Calculating ESG Risk

The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.


Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.

Grünenthal Pharma GmbH & Co. KG's Exposure is Medium



Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.

Grünenthal Pharma GmbH & Co. KG's Management of ESG Material Risk is Strong


How do the ESG Risk Ratings work?

Top Material ESG Issues for Grünenthal Pharma GmbH & Co. KG

Understand how exposed companies are to specific material ESG issues and how well companies are managing these issues.

blurred material ESG issues

What are Material ESG Issues?

Material ESG issues are issues that are considered to be financially material to a given company in a relevant sub-industry.

Controversy Rating

Highest Controversy level that has impacted Grünenthal Pharma GmbH & Co. KG's ESG Risk Rating in the last three years

Highest Controversy Level

blurred controversy level

Contributing Events

blurred controversy events

Highest Controversy Events Locations

world map blurred
Get in Touch Contact us to learn more about our Controversies Research Report

Learn how the ESG Risk Ratings are used by our clients


Leverage Sustainalytics' ESG Risk Ratings to understand and promote your corporate ESG performance with internal and external stakeholders.

Banks and Lenders

Banks and lenders can use our ESG Risk Ratings and data as a part of a broader analysis of their clients as well as for innovative product solutions such as sustainability linked loans.


The ESG Risk Ratings can help investors to identify, understand and manage ESG risks at the security and portfolio level with the aim of improving the long-term performance of their equity and fixed income securities.